Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAXC | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | NDUFS2 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | HCFC1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
mRNA | DPYSL4 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
mRNA | TOX3 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ST18 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | NANOS3 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ST8SIA3 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | H2AFY | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |